CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-05 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) | −99,442 | 85,080 | ||
| 2023-12-04 | Doerfler Douglas President and CEO | Option exercise | +25,008 | $0.04 | $1K | 358,205 |
| 2023-12-04 | Doerfler Douglas President and CEO | Sale | −25,008 | $5.01 | $125K | 333,197 |
| 2023-12-04 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) | −25,008 | 184,522 | ||
| 2023-12-01 | Doerfler Douglas President and CEO | Option exercise | +20,200 | $0.04 | $808 | 353,397 |
| 2023-12-01 | Doerfler Douglas President and CEO | Sale | −20,200 | $5.00 | $101K | 333,197 |
| 2023-12-01 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) | −20,200 | 209,530 | ||
| 2023-11-29 | Doerfler Douglas President and CEO | Option exercise | +5,350 | $0.04 | $214 | 338,547 |
| 2023-11-29 | Doerfler Douglas President and CEO | Sale | −5,350 | $5.00 | $27K | 333,197 |
| 2023-11-29 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) | −5,350 | 229,730 | ||
| 2023-11-27 | Johnston John Joseph Director | Option exercise 10b5-1 | +5,000 | $2.14 | $11K | 125,583 |
| 2023-11-27 | Johnston John Joseph Director | Sale 10b5-1 | −5,000 | $4.59 | $23K | 120,583 |
| 2023-11-27 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 20,617 | ||
| 2023-11-14 | Johnston John Joseph Director | Option exercise 10b5-1 | +8,717 | $1.64 | $14K | 129,300 |
| 2023-11-14 | Johnston John Joseph Director | Option exercise 10b5-1 | +1,283 | $2.14 | $3K | 130,583 |
| 2023-11-14 | Johnston John Joseph Director | Sale 10b5-1 | −10,000 | $3.71 | $37K | 120,583 |
| 2023-11-14 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −8,717 | 0 | ||
| 2023-11-14 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,283 | 25,617 | ||
| 2023-08-30 | Johnston John Joseph Director | Option exercise 10b5-1 | +2,841 | $1.64 | $5K | 123,424 |
| 2023-08-30 | Johnston John Joseph Director | Sale 10b5-1 | −2,841 | $3.70 | $11K | 120,583 |
Page 9 of 15 · 282 trades